NEW YORK, N.Y. – July 5, 2023 – Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to its Board of Directors. She will contribute extensive experience and strategic insights to support Castor’s mission of making patient-centric trials possible for everyone, anywhere in the world.
“The clinical trial landscape requires collaboration among key stakeholders,” said Hecht. “To support the every changing needs of life science stakeholders including pharmaceutical companies, regulators, and research sites, innovation must occur. Castor’s modular platform is built to make clinical trials of varying size or complexity possible for everyone. I am eager to contribute my expertise and become a part of the company’s journey to make patient-centric trials possible for everyone, anywhere in the world.”
Jeanne Hecht, a Global Business Executive in the clinical research industry, has 25+ years of experience leading successful teams across mature and emerging markets within the product development, pharma services and life sciences space. Before joining Castor, she held multiple key roles at renowned life science organizations namely IQVIA, Median Technologies, and Ora where she held various executive leadership roles responsible for leading and implementing the companies’ global strategy. Her significant expertise in driving businesses will help Castor achieve breakthrough growth in key segments.
“At Castor, we are breaking down silos and making it easier for everyone who is involved in the clinical trial processes,” said Derk Arts, MD, PhD, CEO and Founder of Castor. “Jeanne’s insights and enthusiasm for strategic business development combined with the collective experience of our leadership team and Board, will help facilitate collaboration and further our product positioning in the market.”
Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest-rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug-and-play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, consent, and real-world data capture.
Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security, and reusability of data for researchers worldwide.